172 related articles for article (PubMed ID: 25053565)
1. Endocannabinoid CB1 antagonists inhibit hepatitis C virus production, providing a novel class of antiviral host-targeting agents.
Shahidi M; Tay ESE; Read SA; Ramezani-Moghadam M; Chayama K; George J; Douglas MW
J Gen Virol; 2014 Nov; 95(Pt 11):2468-2479. PubMed ID: 25053565
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
3. 2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.
Yang D; Xue B; Wang X; Yu X; Liu N; Gao Y; Liu C; Zhu H
PLoS One; 2013; 8(5):e64932. PubMed ID: 23741428
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model.
Shi D; Zhan X; Yu X; Jia M; Zhang Y; Yao J; Hu X; Bao Z
Lipids Health Dis; 2014 Nov; 13():173. PubMed ID: 25406988
[TBL] [Abstract][Full Text] [Related]
5. Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes.
Toyoda M; Kitaoka A; Machida K; Nishinakagawa T; Yada R; Kohjima M; Kato M; Kotoh K; Sakamoto N; Shiota G; Nakamuta M; Nakashima M; Enjoji M
Int J Mol Med; 2011 May; 27(5):619-24. PubMed ID: 21331443
[TBL] [Abstract][Full Text] [Related]
6. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
[TBL] [Abstract][Full Text] [Related]
7. Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles.
Hu L; Li J; Cai H; Yao W; Xiao J; Li YP; Qiu X; Xia H; Peng T
Antiviral Res; 2017 Dec; 148():5-14. PubMed ID: 29074218
[TBL] [Abstract][Full Text] [Related]
8. Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.
Wu HM; Yang YM; Kim SG
Mol Pharmacol; 2011 Nov; 80(5):859-69. PubMed ID: 21803969
[TBL] [Abstract][Full Text] [Related]
9. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
10. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
11. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
12. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
[TBL] [Abstract][Full Text] [Related]
13. [Antiviral activities of ISG20 against hepatitis C virus].
Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
15. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
Kanda T; Steele R; Ray R; Ray RB
J Virol; 2007 Jan; 81(2):669-76. PubMed ID: 17079316
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Involvement of the Endocannabinoid System in TENS-Induced Antinociception.
de Oliveira HU; Dos Santos RS; Malta IHS; Pinho JP; Almeida AFS; Sorgi CA; Peti APF; Xavier GS; Reis LMD; Faccioli LH; Cruz JDS; Ferreira E; Galdino G
J Pain; 2020; 21(7-8):820-835. PubMed ID: 31785404
[TBL] [Abstract][Full Text] [Related]
18. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
Irwin N; Hunter K; Frizzell N; Flatt PR
Eur J Pharmacol; 2008 Feb; 581(1-2):226-33. PubMed ID: 18191122
[TBL] [Abstract][Full Text] [Related]
20. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.
Elbadawy HM; Mohammed Abdul MI; Aljuhani N; Vitiello A; Ciccarese F; Shaker MA; Eltahir HM; Palù G; Di Antonio V; Ghassabian H; Del Vecchio C; Salata C; Franchin E; Ponterio E; Bahashwan S; Thabet K; Abouzied MM; Shehata AM; Parolin C; Calistri A; Alvisi G
Viruses; 2020 Sep; 12(9):. PubMed ID: 32962117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
